Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy
Study Details
Study Description
Brief Summary
Follow-up study within the Whitehall II study, selecting 800 participants for further neuropsychological, clinical and imaging (MRI) examinations to examine brain structure and function in relation to age-related diseases and the modifiable and non-modifiable factors affecting resilience against and vulnerability to adverse brain changes.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
A total of 6035 civil servants participated in the WHII Phase 11 clinical examination in 2012-2013. A random sample of 800 of these participants was included in a sub-study comprising an MRI brain scan, a detailed clinical and cognitive assessment, and collection of blood and buccal mucosal samples for the characterisation of immune function and associated measures. Data collection for this sub-study started in 2012 and was completed by in 2016. The participants, for whom social and health records have been collected since 1985, were between 60-85 years of age at the time the MRI study started. The pre-specified clinical and cognitive assessment protocols, the state-of-the-art MRI sequences and latest pipelines for analyses of this sub-study have been published and are attached to this application.
Study Design
Outcome Measures
Primary Outcome Measures
- Neuropsychological measure 1 [2012-2016]
National Adult Reading Test (premorbid intellectual ability)
- Neuropsychological measure 2 [2012-2016]
Montreal Cognitive Assessment (MoCA)
- Neuropsychological measure 3 [2012-2016]
Rey Complex Figure copy and delayed recall (visual episodic memory)
- Neuropsychological measure 4 [2012-2016]
Hopkins Verbal Learning Test Revised (verbal episodic memory)
- Neuropsychological measure 5 [2012-2016]
CANTAB Simple and Choice Reaction Time (processing speed)
- Neuropsychological measure 6 [2012-2016]
WAIS-R Digit Symbol Test (processing speed)
- Neuropsychological measure 7 [2012-2016]
Trail Making Test A and B (processing speed/executive functioning)
- Neuropsychological measure 8 [2012-2016]
WAIS-R Digit Span forward and backwards (executive functioning)
- Neuropsychological measure 9 [2012-2016]
Graded Naming Test (semantic memory)
- MRI Measures 1 [2012-2016]
Siemens 3T - T1-weighted scan (MPRAGE) using FSL FIRST, FAST, and Freesurfer Volume extractions
- MRI Measures 2 [2012-2016]
Siemens 3T - T1-weighted scan (MPRAGE) using FSL GLM Voxel based analysis for grey matter density analysis
- MRI Measures 3 [2012-2016]
Siemens 3T - T2-weighted scan, clinical and FSL (BIANCA)-based rating of white matter changes
- MRI Measures 4 [2012-2016]
Siemens 3T Diffusion Tensor Images analyzed with Tract Based Spatial Statistics (TBSS)
- MRI Measures 5 [2012-2016]
Siemens 3T rs-fMRI analyzed with Multivariate Exploratory Linear Optimized Decomposition into Independent Components: MELODIC)
Eligibility Criteria
Criteria
Inclusion Criteria:
- Member of Whitehall II cohort attending at UCL for phase 11
Exclusion Criteria:
- Not suitable for MRI, travelling to Oxford, seriously physically ill
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Oxford | Oxford | England | United Kingdom | OX3 7JX |
Sponsors and Collaborators
- University of Oxford
- University College, London
Investigators
- Principal Investigator: Klaus P Ebmeier, MD, University of Oxford
Study Documents (Full-Text)
None provided.More Information
Additional Information:
- Whitehall Imaging Oxford
- PREDICTING MRI ABNORMALITIES WITH LONGITUDINAL DATA OF THE WHITEHALL II SUBSTUDY (MRC Website)
- Whitehall II (also known as the Stress and Health Study)
Publications
None provided.- MSD/IDREC/C1/2011/71